L&T Technology Services (LTTS) has unveiled an Al-powered digital twin platform for respiratory diagnostics, leveraging NVIDIA technology. The solution aims to enhance diagnostic accuracy and improve patient care by creating 3D models of lung anatomy. The technology will be showcased at the Radiological Society of North America (RSNA) 2025. It offers clinicians interactive visualization and navigation support for complex procedures. This platform promises to transform the treatment of lung cancer and other respiratory conditions.
Next-Gen Respiratory Diagnostics
L&T Technology Services (LTTS) is developing a next-generation Al-powered digital twin platform intended for lung navigation and respiratory diagnostics. This innovative platform combines Al-driven diagnostics with cutting-edge NVIDIA Al infrastructure. The primary goal is to deliver scalable and low-latency solutions that will enhance diagnostic precision and make healthcare more accessible to providers globally.
Powered by NVIDIA Technology
The new LTTS solution, set to be unveiled at the Radiological Society of North America (RSNA) 2025, leverages NVIDIA MONAI for precise medical image segmentation and NVIDIA TensorRT to optimize Al inference. By integrating with CT imaging, the platform creates detailed 3D digital twins of lung anatomy. These twins provide visualization of airways, blood vessels, lung lobes, and lesions.
Clinical Impact
The biological digital twin enables interactive visualization and precise path planning. It also offers navigation support for bronchoscopy, which helps clinicians navigate complex procedures more efficiently. LTTS’ engineering expertise transforms static snapshots into living models, evolving with the patient to mirror real-world anatomy. This technology facilitates improvements in surgical planning and care for conditions like lung cancer, COPD, and infectious diseases.
Executive Perspectives
Alind Saxena, Executive Director and President of Mobility and Tech at L&T Technology Services, stated that the collaboration with NVIDIA combines LTTS’ expertise in Al-driven diagnostics and predictive analytics with NVIDIA’s modeling and visualization platform. This enables the engineering of a digital twin platform that enhances diagnostic accuracy and gives clinicians a real-time planning tool.
David Niewolny, Director of Business Development for Healthcare/Medical at NVIDIA, mentioned that this collaboration demonstrates how NVIDIA is empowering the healthcare industry with accelerated computing and Al innovation. LTTS is enabling transformative solutions that bring real-time Al and biological digital twins to clinical practice, to achieve better patient outcomes.
Source: BSE